Relaxin signalling in primary cultures of human myometrial cells

Molecular Human Reproduction

Volumn 14, Issue 10, 2008, Pages 603-611

  Heng, Kee ^a   Ivell, Richard ^a   Wagaarachchi, Prabhath ^b   Anand Ivell, Ravinder ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

Human myometrium; INSL3; Menstrual cycle; Relaxin; Uterine quiescence

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; PROTEIN INSL 3; PROTEIN RXFP1; PROTEIN RXFP2; RELAXIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOMETRIUM; EXON; FEMALE; HUMAN; HUMAN CELL; MATERNAL SERUM; MENSTRUAL CYCLE; MYOMETRIUM; NIDATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THIRD TRIMESTER PREGNANCY; UTERUS CONTRACTILITY;

1-METHYL-3-ISOBUTYLXANTHINE; CELLS, CULTURED; CYCLIC AMP; FEMALE; FORSKOLIN; HUMANS; INSULIN; MYOMETRIUM; PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RELAXIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

RATTUS; SUIDAE;

EID: 58249103037     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gan051     Document Type: Article

References (35)

1. Anand-Ivell RJK, Relan V, Balvers M, Fritsch M, Bathgate RAD, Ivell R. Expression of the Insulin-like peptide 3 (INSL3) hormone-receptor (LGR8) system in the testis. Biol Reprod 2006;74945-953.
2. Anand-Ivell R, Heng K, Bartsch O, Ivell R. Relaxin signalling in THP-1 cells uses a novel phosphotyrosine-dependent pathway. Mol Cell Endocrinol 2007;272:1-13.
3. Bamberger AM, Ivell R, Balvers M, Kelp B, Bamberger CM, Riethdorf L, Loning T. Relaxin-like factor (RLF): A new specific marker for Leydig cells in the ovary. Int J Gynecol Pathol 1999;18:163-168.
4. Bartsch O, Bartlick B, Ivell R. Relaxin signalling links tyrosine phosphorylation to phosphodiesterase and adenylyl cyclase activity. Mol Hum Reprod 2001;7:799-809.
5. Bartsch O, Bartlick B, Ivell R. Phosphodiesterase 4 inhibition synergizes with relaxin signalling to promote decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 2004;89 324-334.
6. Bathgate RA, Hsueh AJ, Ivell R, Sanborn BM, Sherwood OD, Summers RJ. International Union of Pharmacology. Recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006;58:7-31.
7. Berg G, Andersson RG, Ryden G. Beta-adrenergic receptors in human myometrium during pregnancy: Changes in the number of receptors after beta-mimetic treatment. Am J Obstet Gynecol 1985;151:392-396.
8. Bryant-Greenwood GD, Schwabe C. Human relaxins: Chemistry and biology. Endocr Rev 1994;15:5-26.
9. Dodge KL, Carr DW, Sanborn BM. Protein kinase A anchoring to the myometrial plasma membrane is required for cyclic adenosine 3′5′-monophosphate regulation of phosphatidylinositide turnover. Endocrinology 1999;140:5165-5170.
10. Downing SJ, Hollingsworth M. Action of relaxin on uterine contractions - a review. J Reprod Fertil 1993;99:275-282.
11. Fahnenstich J, Nandy A, Milde-Langosch K, Schneider-Merck T, Walther N, Gellersen B. Promyelocytic leukaemia zinc finger protein (PLZF) is a glucocorticoid- and progesterone-induced transcription factor in human endometrial stromal cells and myometrial smooth muscle cells. Mol Hum Reprod 2003;9:611-623.
12. Halls M, Bathgate RA, Summers RJ. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signalling by distinct mechanisms. Mol Pharmacol 2006;70:214-226.
13. Hombach-Klonisch S, Seeger S, Tscheudschilsuren G, Buchmann J, Huppertz B, Seliger G, Fischer B, Klonisch T. Cellular localization of human relaxin-like factor in the cyclic endometrium and placenta. Mol Hum Reprod 2001;7: 349-356.
14. Ivell R, Bathgate RAD. Hypothesis: Neohormone systems as exciting targets for drug development. Trends Endocrinol Metab 2006;17 123.
15. Ivell R, Einspanier A. Relaxin peptides are new global players. Trends Endocrinol Metab. 2002;13:343-348.
16. Ivell R, Balvers M, Pohnke Y, Telgmann R, Bartsch O, Milde-Langosch K, Bamberger AM, Einspanier A. Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod Biol Endocrinol 2003;1:114.
17. Kuznetsova L, Plesneva S, Derjabina N, Omeljaniuk E, Pertseva M. On the mechanism of relaxin action: The involvement of adenylyl cyclise signalling system. Reg Peptides 1999;80:33-39.
18. Lane B, Oxberry W, Mazella J, Tseng L. Decidualization of human endometrial stromal cells in vitro: Effects of progestin and relaxin on the ultrastructure and production of decidual secretory proteins. Hum Reprod 1994;9: 259-266.
19. MacLennan AH, Grant P, Ness D, Down A. Effect of porcine relaxin and progesterone on rat, pig and human myometrial activity in vitro. J Reprod Med 1986;31:43-49.
20. Mehats C, Tanguy G, Dallot E, Robert B, Rebourcet R, Ferre F, Leroy MJ. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3′,5′-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture. Endocrinology 1999;140:3228-3237.
21. Muda M, He C, Martini PG, Ferraro T, Layfield S, Taylor D, Chevrier C, Schweickhardt R, Kelton C, Ryan PL et al. Splice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexity. Mol Hum Reprod 2005;11:591-600.
22. Nguyen BT, Dessauer CW. Relaxin stimulates protein kinase C zeta translocation: Requirement for cyclic adenosine 3′,5′-monophosphate production. Mol Endocrinol 2005;19:1012-1023.
23. Nguyen BT, Yang L, Sanborn BM, Dessauer CW. Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3′,5′-monophosphate by relaxin. Mol Endocrinol 2003;17 1075-1084.
24. Nistri S, Bigazzi M, Bani D. Relaxin as a cardiovascular hormone: physiology, pathophysiology and therapeutic promises. Cardiovasc Hematol Agents Med Chem 2007;5:101-108.
25. Palejwala S, Tseng L, Wojtczuk A, Weiss G, Goldsmith LT. Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endometrial cells. Biol Reprod 2002;66:1743-1748.
26. Pertseva M, Shpakov A, Kuznetzova L, Plesneva S, Omeljaniuk E. Adenylyl cyclise signalling mechanisms of relaxin and insulin action: similarities and differences. Cell Biol Int 2006;30:533-540.
27. Peterson LK, Svane D, Uldbjerg N, Forman A. Effects of human relaxin on isolated rat and human myometrium. Obstet Gynecol 1991;78 757-762.
28. Samuel CS, Hewitson TD, Unemori EN, Tang ML. Drugs of the future: The hormone relaxin. Cell Mol Life Sci 2007;64:1539-1557.
29. Sanborn BM, Kuo HS, Weisbrodt NW, Sherwood OD. The interaction of relaxin with the rat uterus. I. Effect on cyclic nucleotide levels and spontaneous contractile activity. Endocrinology 1980;106 1210-1215.
30. Scott DJ, Tregear GW, Bathgate RA. LGR7 truncate is a splice variant of the relaxin receptor LGR7 and is a relaxin antagonist in vitro. Ann NY Acad Sci 2005;1041:22-26.
31. Sherwood OD. Relaxin. In: Knobil E, Neill JD (eds). The Physiology of Reproduction, 2nd edn. New York: Raven Press, 1994,861-1009.
32. Tarlatzis BC, Pados G. Oocyte donation: Clinical and practical aspects. Mol Cell Endocrinol 2000;161:99-102.
33. Unemori EN, Erikson ME, Rocco SE, Sutherland KM, Parsell DA, Mak J, Grove BH. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod 1999;14:800-806.
34. Yuan W, Lopez-Bernal A. Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth 2007;7 Suppl. 1):S10.
35. Zhong M, Murtazina DA, Phillips J, Ku CY, Sanborn BM. Multiple Signals Regulate PLC beta 3 in Human Myometrial Cells. Biol Reprod 2008; 78:1007-1017.